Trial News & Events

Medicinova to Initiate Clinical Trial of MN-166

Medicinova, Inc announced the FDA approval to initiate a clinical trial of MN-166 (ibudilast) ALS. The principal investigator of the study is Benjamin Rix Brooks, MD, of Carolinas Neuromuscular/ALS-MDA Center in Charlotte, NC. Read the full press release here.…

2014 Regional CRLI Highlights

The second annual Philadelphia Clinical Research Learning Institute was held May 2nd through the 4th in Philadelphia, PA.